In 2024, the Greatest Demand Was For Medicines For the Treatment of Cardiovascular Diseases

According to the results of 2024, Ukrainians purchased most of the medicines manufactured by “Darnytsia” Pharmaceutical Company for the treatment of cardiovascular diseases, neurological disorders, as well as diseases of the digestive system and skin.

The largest growth in 2024 was demonstrated by Darnytsia's cardiology product line. The company's sales in money terms increased by 27% compared to 2023. In general, the market of drugs for the treatment of cardiovascular diseases in Ukraine grew by 18% in 2024.

Sales of Darnytsia's medicinal products used to treat neurological disorders also increased. Compared to the previous year, the company's sales in monetary terms increased by 24%, which is significantly higher than the overall market, which grew by 16%.

In 2024, drugs for the treatment of the digestive system were also in demand. Sales in the market of such drugs in monetary terms increased by 19%. At the same time, Darnytsia's sales in 2024 increased by 23%.

In addition, Ukrainians purchased medicines for the treatment of dermatological diseases.Thus, the overall market grew by 16%, while Darnytsia's sales grew by 27%.

“The figures show that in 2024 “Darnytsia” achieved a significant increase in sales of medicines for the treatment of the most common diseases in Ukraine. Our company's performance exceeds the overall market indicators. This indicates the high efficiency and popularity of “Darnytsia” products among Ukrainian consumers. We appreciate this trust,” says Serhii Kolchyk, Head of Analytics and Digital Innovations Department of “Darnytsia” Pharmaceutical Company.